Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 14/20 | 0.81 |
| ▸ | LPAR2 | Q9HBW0 | 10/20 | 0.81 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.81 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.51 |
| ▸ | CDC25A | P30304 | 1/20 | 0.48 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.44 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.44 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid Monododecyl Ester SCHEMBL2049086 | 1.00 | LPAR3 (0.81) | LPAR3LPAR2LPAR1LPAR5CDC25A | |
| Tetrahydrofuran SCHEMBL27900225 | 0.93 | LPAR3 (0.75) | LPAR3LPAR2LPAR1LPAR5CDC25A | |
| Tetrahydrofuran SCHEMBL28299623 | 0.93 | LPAR3 (0.75) | LPAR3LPAR2LPAR1LPAR5CDC25A | |
| SCHEMBL7557287 | 0.92 | LPAR3 (0.74) | LPAR3LPAR2LPAR1LPAR5CDC25A | |
| Phosphoric Acid Monodecyl Ester SCHEMBL27465279 | 0.92 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5 | |
| Phosphoric Acid Monododecyl Ester SCHEMBL27793114 | 0.92 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5 | |
| Fluoride SCHEMBL28218528 | 0.92 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5 | |
| Tetrahydrofuran SCHEMBL28178307 | 0.91 | LPAR3 (0.71) | LPAR3LPAR2LPAR1LPAR5CDC25A | |
| SCHEMBL2788530 | 0.90 | LPAR3 (0.77) | LPAR3LPAR2LPAR1LPAR5CDC25A | |
| Oxirane SCHEMBL8050218 | 0.90 | LPAR3 (0.79) | LPAR3LPAR2LPAR1LPAR5LPAR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260070845-A1 | LOW-DENSITY HIGH-STRENGTH CONCRETE AND RELATED METHODS USING FOAMED GLASS AGGREGATES | AERO AGGREGATES OF NORTH AMERICA, LLC (US) | 2026-03-12 | — | — | US | disclosed |
| US-12312272-B2 | Low-density high-strength concrete and related methods | SEBASTOS TECHNOLOGIES, INC. (US) | 2025-05-27 | — | — | US | disclosed |
| US-20240043332-A1 | LOW-DENSITY HIGH-STRENGTH CONCRETE AND RELATED METHODS | Sebastos Technologies Inc. | 2024-02-08 | — | — | US | disclosed |
| US-11577998-B2 | Low-density high-strength concrete and related methods | Sebastos Technologies Inc. (US) | 2023-02-14 | — | — | US | disclosed |
| US-20210147296-A1 | LOW-DENSITY HIGH-STRENGTH CONCRETE AND RELATED METHODS | Sebastos Technologies Inc. | 2021-05-20 | — | — | US | disclosed |
| US-10759701-B1 | Low-density high-strength concrete and related methods | Sebastos Technologies Inc. (US) | 2020-09-01 | — | — | US | disclosed |
| US-10556830-B2 | Low-density high-strength concrete and related methods | Sebastos Technologies Inc. (US) | 2020-02-11 | — | — | US | disclosed |
| CN-110312690-A | Concrete composition and preparation method thereof | 信越化学工业株式会社 | 2019-10-08 | — | — | CN | disclosed |
| US-10377669-B2 | Low-density high-strength concrete and related methods | Sebastos Technologies Inc. (US) | 2019-08-13 | — | — | US | disclosed |
| US-20190169071-A1 | LOW-DENSITY HIGH-STRENGTH CONCRETE AND RELATED METHODS | SEBASTOS TECH INC (US) | 2019-06-06 | — | — | US | disclosed |
| US-10239790-B2 | Low-density high-strength concrete and related methods | Sebastos Technologies Inc. (US) | 2019-03-26 | — | — | US | disclosed |
| US-20180290927-A1 | LOW-DENSITY HIGH-STRENGTH CONCRETE AND RELATED METHODS | Sebastos Technologies Inc. | 2018-10-11 | — | — | US | disclosed |
| US-20180029939-A1 | LOW-DENSITY HIGH-STRENGTH CONCRETE AND RELATED METHODS | Sebastos Technologies Inc. | 2018-02-01 | — | — | US | disclosed |
| US-9732002-B2 | Low-density high-strength concrete and related methods | Sebastos Technologies Inc. (US) | 2017-08-15 | — | — | US | disclosed |
| US-20160060169-A1 | Low-density high-strength concrete and related methods | Sebastos Technologies Inc. (US) | 2016-03-03 | — | — | US | disclosed |
| CN-102149747-B | Multibranched polyalkylene glycol polymer and manufacturing method thereof, and cement admixture | NIPPON CATALYTIC CHEM IND | 2015-04-29 | — | — | CN | disclosed |
| US-6545067-B1 | Polycarboxylate-based plasticizer and, as an air detrainer, butoxylated polyalkylenepolyamines or salts thereof mixed with a mineral building material comprising cement. | BASF AKTIENGESELLSCHAFT (DE) | 2003-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260070845-A1 | LOW-DENSITY HIGH-STRENGTH CONCRETE AND RELATED METHODS USING FOAMED GLASS AGGREGATES | FBXL19, S100A9, ITGAM | LPAR3 3247/4885LPAR2 3310/4885LPAR1 3196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.